chr4-183099615-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_024949.6(WWC2):āc.124C>Gā(p.Arg42Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,360,504 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Exomes š: 0.000012 ( 0 hom. )
Consequence
WWC2
NM_024949.6 missense
NM_024949.6 missense
Scores
5
8
6
Clinical Significance
Conservation
PhyloP100: 1.62
Genes affected
WWC2 (HGNC:24148): (WW and C2 domain containing 2) This gene encodes a member of the WW-and-C2-domain-containing family of proteins. Members of this family have two N-terminal WW domains that mediate binding to target proteins harboring L/PPxY motifs, an internal C2 domain for membrane association, and C-terminal alpha protein kinase C binding sites and class III PDZ domain-interaction motifs. Proteins of this family are able to form homo- and heterodimers and to modulate hippo pathway signaling. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WWC2 | NM_024949.6 | c.124C>G | p.Arg42Gly | missense_variant | 1/23 | ENST00000403733.8 | NP_079225.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WWC2 | ENST00000403733.8 | c.124C>G | p.Arg42Gly | missense_variant | 1/23 | 5 | NM_024949.6 | ENSP00000384222.3 | ||
WWC2 | ENST00000448232.6 | c.124C>G | p.Arg42Gly | missense_variant | 1/23 | 5 | ENSP00000398577.2 | |||
WWC2 | ENST00000513834.5 | c.124C>G | p.Arg42Gly | missense_variant | 1/23 | 5 | ENSP00000425054.1 | |||
WWC2 | ENST00000508614.5 | n.124C>G | non_coding_transcript_exon_variant | 1/4 | 3 | ENSP00000423238.1 |
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151140Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000111 AC: 1AN: 89776Hom.: 0 AF XY: 0.0000201 AC XY: 1AN XY: 49856
GnomAD3 exomes
AF:
AC:
1
AN:
89776
Hom.:
AF XY:
AC XY:
1
AN XY:
49856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000124 AC: 15AN: 1209364Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 8AN XY: 592794
GnomAD4 exome
AF:
AC:
15
AN:
1209364
Hom.:
Cov.:
30
AF XY:
AC XY:
8
AN XY:
592794
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000662 AC: 1AN: 151140Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73792
GnomAD4 genome
AF:
AC:
1
AN:
151140
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
73792
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2024 | The c.124C>G (p.R42G) alteration is located in exon 1 (coding exon 1) of the WWC2 gene. This alteration results from a C to G substitution at nucleotide position 124, causing the arginine (R) at amino acid position 42 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Uncertain
D;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
P;.;.
Vest4
MutPred
Gain of glycosylation at T46 (P = 0.0053);Gain of glycosylation at T46 (P = 0.0053);Gain of glycosylation at T46 (P = 0.0053);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at